Characterization of clofibrate-induced retrograde Golgi membrane movement to the endoplasmic reticulum: Clofibrate distinguishes the Golgi from the trans Golgi network
M. Nakamura et al., Characterization of clofibrate-induced retrograde Golgi membrane movement to the endoplasmic reticulum: Clofibrate distinguishes the Golgi from the trans Golgi network, BIOS BIOT B, 65(8), 2001, pp. 1812-1823
Clofibrate-induced retrograde Golgi membrane movement was blocked or retard
ed when NRK cells were treated with sodium azide/2-deoxyglucose, nocodazole
, taxol, and destruxin B, indicating that it depends on energy, and the dyn
amic state of microtubules, and being acidic or vacuolar-type ATPase functi
on. PDMP and phospholipase A(2) inhibitors also blocked it. These character
istics are similar to those of brefeldin A (BFA) and nordihydroguaiaretic a
cid (NDGA), inducers of retrograde Golgi membrane movement. However, clofib
rate was distinguished from BFA in that BFA action was insensitive to phosp
holipase A2 inhibitors and from NDGA in that NDGA stabilized microtubules a
gainst nocodazole and its action was almost insensitive to taxol. The trams
Golgi network (TGN) was resistant to clofibrate, while BFA and NDGA disper
sed it. To our knowledge, clofibrate is the first drug to show such differe
nt effects on the Golgi and TGN and, therefore, is expected to be a useful
tool to distinguish their architecture and/or membrane dynamics.